1

Mini-antibodies Reactivate tumor suppressor p53: The New Pathway for Tumor Management

News Discuss 
A major advance in cancer research is occurring with the use of VHH fragments to reactivate mutated p53. This crucial malignant suppressor protein is frequently inactivated in various kinds of malignancies, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story